Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

This means is that if a company is charging ‘X’ for a particular medicine in a particular country and charging ‘2X’ in the US ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...